Hydrocortisone Dosing in Septic Shock with Hypotension
For adults with septic shock that remains hypotensive despite adequate fluid resuscitation and moderate-to-high dose vasopressor therapy, administer intravenous hydrocortisone at 200 mg per day for at least 3 days at full dose. 1, 2
Indications for Hydrocortisone
- Only use hydrocortisone when hemodynamic stability cannot be achieved with adequate fluid resuscitation and vasopressor therapy 1, 3
- Do not use corticosteroids for sepsis in the absence of shock 1
- The threshold for "adequate vasopressor therapy" typically means moderate-to-high dose norepinephrine (generally >0.1-0.2 mcg/kg/min) 1, 2
Dosing Regimen
The standard dose is 200 mg per day of hydrocortisone, administered either as:
The continuous infusion is preferred over intermittent boluses based on guideline recommendations, though both are acceptable 1
Duration and Tapering
- Continue full-dose hydrocortisone for at least 3 days before considering any dose reduction 2, 3
- Begin tapering when vasopressors are no longer required, not before 1, 2
- Taper gradually over 6-14 days rather than stopping abruptly to avoid rebound inflammation and hemodynamic deterioration 2
- Do not use a fixed duration approach; instead, taper based on clinical response and vasopressor requirements 2
Pediatric Dosing
For children with septic shock at risk for adrenal insufficiency who remain in shock despite epinephrine or norepinephrine:
- Dosing range: 1-2 mg/kg/day for stress coverage, up to 50 mg/kg/day titrated to reversal of shock 1
- May be administered as intermittent or continuous infusion 1
Maternal/Pregnancy Considerations
For pregnant patients with septic shock:
- Use the same adult dosing: hydrocortisone 200 mg per day 1
- Typical regimen: 50 mg IV every 6 hours or continuous infusion 1
What NOT to Do: Common Pitfalls
- Do not use the ACTH stimulation test to identify patients who should receive hydrocortisone 1, 3
- Do not use hydrocortisone doses >400 mg per day—higher doses provide no additional benefit and may increase harm 2
- Avoid etomidate for intubation in patients who may require hydrocortisone, as it suppresses the HPA axis and worsens outcomes 2, 6
- Do not stop hydrocortisone abruptly—this causes hemodynamic and immunologic rebound 2
- Do not use hydrocortisone if hemodynamic stability is achieved with fluids and vasopressors alone 1, 3
Expected Clinical Response
When hydrocortisone is appropriately indicated, expect:
- Rapid decrease in vasopressor requirements within 2-24 hours 7, 8
- Improved mean arterial pressure within hours of initiation 7, 8, 9
- Enhanced catecholamine responsiveness and restoration of vascular tone 7, 9
- Improved lactate clearance indicating better tissue perfusion 8
Monitoring During Treatment
- Monitor serum sodium for hypernatremia, especially if treatment extends beyond 48-72 hours 2, 4
- Monitor blood glucose for hyperglycemia 2
- Assess for superinfection, though risk appears minimal at physiologic doses 3, 5
- Check clinical response after 2-3 days to determine if therapy should continue 2